Reflow Medical Completes Enrollment in DEEPER CORONARY Study Evaluating Spur Elute Coronary Sirolimus-Eluting Retrievable Scaffold System for In-Stent Restenosis

Reflow Medical announces the completion of enrollment in the DEEPER CORONARY study, evaluating the Spur Elute Coronary Sirolimus-Eluting Retrievable Scaffold System for in-stent restenosis (ISR) treatment. The first-in-human study successfully treated nine subjects and will continue to follow up for one year. The Spur Elute system is designed to reduce neointimal hyperplasia and recoil of the hyperplastic neointima without leaving a permanent metallic implant behind.